BUY Canara Bank — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Intraday)10 Sept 2026, 9:24 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Canara Bank received credit ratings from ICRA for various instruments including Basel III Tier I and Tier II bonds, and Certificates of Deposit. Ratings were reaffirmed, assigned, or withdrawn for dif
BSE · Company Update·8 Sept · yesterday
Canara Bank received credit ratings from India Ratings & Research. The issuer rating was affirmed as IND AAA/Stable. Basel III AT1 bonds were assigned IND AA+/Stable, and Infrastructure Bonds and Base
BSE · Company Update·4 Sept · 5d ago
Canara Bank eyes $2 billion overseas bond raise
NewsEt-Markets·4 Sept · 6d ago
Canara Bank's Board of Directors approved raising foreign currency funds up to USD 2,000 Mn through issuance of Senior Unsecured Foreign Currency Bonds under the existing USD 3 Bn Medium Term Note Pro
BSE · Board Meeting·3 Sept · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Canara Bank
- BUY — Rachna Vaidya23 Oct 2026 · Same day · target ₹122 · SL hit
- BUY — Ashish Bahety, Profitmart Securities21 Oct 2026 · Same day · target ₹125 · SL hit
- BUY — Laxmikant Shukla, YES Securities19 Oct 2026 · ~2 weeks · target ₹126 · Active
- BUY — BOB Capital Markets15 Oct 2026 · ~1 year · target ₹150 · Active
- SELL — Morgan Stanley15 Oct 2026 · ~1 year · target ₹109 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

